Drug Development
AstraZeneca Halts Development of Opioid Use Disorder Drug Due to Antifungal Interaction
AstraZeneca, Opioid Use Disorder, Drug Development, Antifungal Interaction, Clinical Trials
Enveda Secures $130 Million in Funding for Innovative Therapies in Inflammation, Obesity, and Beyond
Enveda, Microsoft-backed, $130M funding, Inflammation & Immunology (I&I), obesity, biotech, pharma, drug development
Aizen Therapeutics Unveils AI-Driven ‘Mirror Peptide’ Platform to Revolutionize Drug Development
Aizen Therapeutics, Caltech spinout, AI-driven platform, mirror peptides, drug development, biologic medicine, cancer treatment
Pfizer Expands Collaboration with Flagship Pioneering, Adding Ampersand Biomedicines and Montai Therapeutics
Pfizer, Flagship Pioneering, Ampersand Biomedicines, Montai Therapeutics, strategic partnership, drug development, obesity, non-small cell lung cancer
Evotec Shares Soar as Private Equity Firm Triton Considers Takeover Bid
Evotec, Triton Partners, takeover bid, private equity, drug development, pharmaceuticals
Novo Nordisk Terminates Development of Kidney Disease Drug Ocedurenone After Phase 3 Failure
Novo Nordisk, ocedurenone, kidney disease, hypertension, Phase 3 trial, CLARION-CKD, drug development failure
Novo Nordisk Secures $285 Million Biobucks Deal with Ascendis Pharma for Monthly GLP-1 Agonist Development
Novo Nordisk, Ascendis Pharma, GLP-1 agonist, biobucks deal, pharmaceutical development
Insights from Jade CEO: Reverse Merger and IgAN Drug Development
Jade CEO, Reverse Merger, IgAN Drugs, Pharmaceutical Development, Biotech Mergers
Breakthrough in Cryptosporidiosis Treatment: New Drugs Show Promise in Animal Models
Cryptosporidiosis, new treatments, animal models, drug development, parasitic diseases
Eli Lilly Expands Global Innovation Reach with New Research Centers in China
Eli Lilly, China, Research Centers, Innovation, Gateway Labs, Biotechnology, Drug Development